SXTP

60 Degrees Pharmaceuticals, Inc.

SXTPW·NasdaqCM

FollowCompareShare

0.02970.0000 (0.00%)today

As of Oct 20, 3:46 PM EDT · May be delayed up to 15 min · USD

1D5D1M6MYTD1Y5Y10Y20YAll

MountainLineCandles

Indicators

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.0297

Open0.0503

Day range0.02840.0328

52-week range0.02840.0328

Off day high−9.45%

Off 52-week high−9.45%

Volume1.00

Avg. volume (3M)—

Market cap—

EPS (TTM)—

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)—

Shares outstanding—

Short interest—

Earnings date—

Analyst target—

Profit margin—

Related companies

Compare ›

Also watched

What visitors to 60 Degrees Pharmaceuticals's page also look at.

Company	Mkt cap	Price	Today
SXTP60 Degrees Pharmaceuticals, IncSXTP	3.08M	0.8759	−1.58%
SKYASkyAI, Inc.SKYAW	—	0.0415	−25.76%
TNONTenon Medical, Inc. WarrantTNONW	—	0.0050	−10.71%
SWVLSwvl Holdings Corp WarrantSWVLW	—	0.0069	−1.43%
REVBRevelation Biosciences, Inc.REVBW	—	0.0061	−29.07%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All SXTPW news ›

markets.businessinsider.com·3d agoPositive

60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results

WASHINGTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc.(NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company fo... 60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results WASHINGTON, Aug. 14, 2026…

markets.businessinsider.com·3d agoPositive

60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules

WASHINGTON, July 30, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP, SXTPW) (“60 Degrees” or the “Company”), a pharmace... 60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under…

markets.businessinsider.com·3d ago

60 Degrees Pharmaceuticals to conclude enrollment in tafenoquine study

60 Degrees Pharmaceuticals (SXTP) announced that it intends to conclude enrollment in its randomized clinical study of tafenoquine in patients h... 60 Degrees Pharmaceuticals to conclude enrollment in tafenoquine study 60 Degrees…

markets.businessinsider.com·3d ago

60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar

Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis (NCT06207370) to be disclosed on October 6, 2026. Key Opinion Leader investor webinar scheduled for October 6, ... 60 Degrees Pharmaceuticals…

markets.businessinsider.com·3d agoPositive

60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA

After a scheduled interim analysis of the severe babesiosis study on October 1, 2026, the DSMB recommended completing the study with the originall... 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will…

markets.businessinsider.com·4d ago

Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP). In a report released today, Brendan Smith from TD Cowen maintained a…

Defense World·5d agoPositive

Comparing Eyepoint Pharmaceuticals (NASDAQ:EYPT) & 60 Degrees Pharmaceuticals (NASDAQ:SXTP)

Posted by Defense World Staff on Oct 17th, 2026 Eyepoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP – Get Free Report) are both small-cap healthcare companies, but which is the better stock?…

Markets Daily·6d agoNegative

60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Stock Short Interest Falls 38.3%

Posted by Mitch Edgeman on Oct 16th, 2026 Read Our Latest Research Report on SXTP 60 Degrees Pharmaceuticals, Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for infectious and…

Defense World·Oct 8Negative

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Stock Price Down 0.9% – Here’s What Happened

Posted by Defense World Staff on Oct 8th, 2026 60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP – Get Free Report)’s share price fell 0.9% during mid-day trading on Wednesday. The stock traded as low as $1.0081 and last traded at $1.10.…

From articles in the 4Search news index.

In the news

11mentions in 30 days

11with it in the headline

Positivesentiment

Mentioned with

Food and Drug Administration5Pfizer5U.S. Food and Drug Administration5Astrazeneca4Degrees Pharmaceuticals Inc.4Degrees Pharmaceuticals3Eli Lilly3Eli Lilly and Company3

People in the coverage

Mitch Edgeman7Michael Walen5Danessa Lincoln4John Galgiani4Kim Johansen4Sarita Garza4

Themes

Healthcare6Health4Lly4Announces2Biotechnology2Conditions2Earnings2EPS2

Most coverage from

1. markets.businessinsider.com6
2. defenseworld.net2
3. accessnewswire.com1
4. daily-tribune.com1
5. themarketsdaily.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.